Abstract

PANI, Jorge Luis Aucapiña  and  LOAIZA, Walter Viterio Jaramillo. Cardiovascular implications of cross hormone therapy in the feminization process. Vive Rev. Salud [online]. 2023, vol.6, n.16, pp.55-65.  Epub Feb 14, 2023. ISSN 2664-3243.  https://doi.org/10.33996/revistavive.v6i16.206.

Today gender identity is an important part of an individual's mental health. Because of the increasing free expression of gender, with a main focus on transgender people, which term refers to a person who perceives themselves as having the opposite sex to the one they were assigned at birth. Among the main treatments to improve this condition are: psychotherapy to help deal with the stress of social rejection, hormone therapy for the process of feminization or masculinization, and surgery. Objective. To determine cardiovascular implications of cross-hormone therapy in the feminization process. Methodology. A literature review was performed, where the risk of cardiovascular disease is evaluated in publications of relevant studies in the field of endocrinology published between 2017 and 2022. The following database was used to search for information, Scielo, Taylor & Francis, PubMed and ScienceDirect, Conclusion. The adverse effects of cross-hormone therapy are of high risk for the feminization process affected the cardiovascular system irreversibly. This is influenced by the types of drugs, route of administration, history of cardiovascular disease and certain habits, which directly affect the development of deep vein thrombosis, obesity, hypertension and diabetes mellitus. Therefore, there are many variables to consider before initiating a process of change, since this requires a multidisciplinary team and continuous follow-up to obtain the expected results.

Keywords : Risk; Therapeutics; Hormones; Feminization.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )